Citations 1
P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Hurd, David D., Voorhees, Peter M. , Rodriguez, Cesar, Tuchman, Sacha, Korde, Neha , Safah, Hana, Bueno, Orlando F. , Feng, Zhongling, Rosenberg, Tanya, Pothacamury, Rajvineeth Kumar, Talati, Chetasi, Kumar, Shaji , Vij, Ravi, Weisel, Katja C , D’Souza, Anita , Teipel, Raphael , Chung, Alfred , Ross, Jeremy A. , Lee, Shane , Jin, Ziyi , Talati, Chetasi
HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e0036307
